Psoriasis: Targets and Therapy (Jun 2021)
Updates on the Treatment of Erythrodermic Psoriasis
Abstract
Yang Lo,1 Tsen-Fang Tsai2 1Department of Dermatology, Cathay General Hospital, Taipei, Taiwan; 2Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence: Tsen-Fang Tsai Tel +886-2-2312-3456 #65734Email [email protected]: Erythrodermic psoriasis (EP) is a rare variant of psoriasis, which is potentially life threatening and often resistant to conventional therapy. Biologics have revolutionized the treatment of plaque-type psoriasis, and shown promise in EP. However, due to the lack of head-to-head studies and the rarity of EP, no high level evidence-based treatment guidelines for EP have been established, and the evidence of treatment of EP is limited to case reports or small case series. Here, we present a narrative review focusing on the up-to-date information for the treatment of EP.Keywords: erythrodermic psoriasis, treatment
